Tissue Regenix Group Plc (TRX) — Working Capital to Net Assets Ratio
Tissue Regenix Group Plc (TRX) has a Working Capital to Net Assets ratio of 52.0% as of June 2025. Working capital of GBX14.88 Million (current assets of GBX22.79 Million minus current liabilities of GBX7.91 Million) is measured against net assets of GBX28.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See TRX days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tissue Regenix Group Plc Working Capital to Net Assets (2008–2024)
This chart shows how Tissue Regenix Group Plc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 52.0%, reflecting working capital of GBX14.88 Million against net assets of GBX28.62 Million GBX. For the complete balance sheet picture, see Tissue Regenix Group Plc total assets.
Annual Working Capital to Net Assets for Tissue Regenix Group Plc (2008–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tissue Regenix Group Plc from 2008 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check TRX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 52.0% | GBX15.12 Million | GBX29.06 Million | GBX21.27 Million | GBX6.16 Million | ▲ +3.1 pp |
| 2023 | 48.9% | GBX14.36 Million | GBX29.36 Million | GBX19.09 Million | GBX4.74 Million | ▲ +2.7 pp |
| 2022 | 46.2% | GBX11.67 Million | GBX25.27 Million | GBX18.32 Million | GBX6.64 Million | ▼ -6.8 pp |
| 2021 | 53.0% | GBX13.07 Million | GBX24.65 Million | GBX16.29 Million | GBX3.22 Million | ▼ -7.4 pp |
| 2020 | 60.4% | GBX16.83 Million | GBX27.85 Million | GBX20.09 Million | GBX3.26 Million | ▲ +31.9 pp |
| 2019 | 28.6% | GBX7.02 Million | GBX24.59 Million | GBX10.14 Million | GBX3.12 Million | ▼ -4.0 pp |
| 2018 | 32.5% | GBX10.60 Million | GBX32.57 Million | GBX14.90 Million | GBX4.30 Million | ▼ -14.7 pp |
| 2018 | 47.3% | GBX18.68 Million | GBX39.52 Million | GBX23.46 Million | GBX4.78 Million | ▲ +0.0 pp |
| 2017 | 47.3% | GBX18.68 Million | GBX39.52 Million | GBX23.46 Million | GBX4.78 Million | ▼ -38.5 pp |
| 2016 | 85.8% | GBX9.90 Million | GBX11.54 Million | GBX11.96 Million | GBX2.06 Million | ▼ -9.9 pp |
| 2016 | 95.8% | GBX28.97 Million | GBX30.25 Million | GBX31.75 Million | GBX2.79 Million | ▼ -0.5 pp |
| 2015 | 96.2% | GBX11.14 Million | GBX11.58 Million | GBX12.24 Million | GBX1.09 Million | ▼ -1.3 pp |
| 2014 | 97.5% | GBX30.53 Million | GBX31.30 Million | GBX32.35 Million | GBX1.82 Million | ▼ -1.5 pp |
| 2013 | 99.0% | GBX38.27 Million | GBX38.64 Million | GBX39.35 Million | GBX1.08 Million | ▼ -0.4 pp |
| 2012 | 99.4% | GBX43.53 Million | GBX43.78 Million | GBX44.55 Million | GBX1.02 Million | ▲ +2.5 pp |
| 2011 | 97.0% | GBX9.54 Million | GBX9.84 Million | GBX9.94 Million | GBX400.37K | ▼ -3.0 pp |
| 2010 | 100.0% | GBX3.67 Million | GBX3.67 Million | GBX3.72 Million | GBX51.12K | ▲ +0.1 pp |
| 2009 | 99.9% | GBX3.63 Million | GBX3.63 Million | GBX3.69 Million | GBX60.53K | ▲ +43.5 pp |
| 2008 | 56.4% | GBX5.46 Million | GBX9.68 Million | GBX5.55 Million | GBX83.52K | — |